ARX:ASX
Aroa Biosurgery Ltd
A$ ०.४८
arrow_downward
-१.०२%(-०.००५०) 1D
नोभेम्बर २०, १६:१०:०८ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.५०
High
A$ ०.५०
Low
A$ ०.४८
Mkt. cap
१६.७८ करोड
Avg. vol.
२.५९ लाख
Volume
१.९२ लाख
P/E ratio
४६.१९
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.५०
High
A$ ०.५०
Low
A$ ०.४८
Mkt. cap
१६.७८ करोड
Avg. vol.
२.५९ लाख
Volume
१.९२ लाख
P/E ratio
४६.१९
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
Nacionale
·
१ घण्टा पहिले
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
The Motley Fool
·
२१ मिनेट पहिले
The S&P 500 Just Entered Correction Territory. Here's What It Means for Investors Right Now.
The National Herald
·
२ मिनेट पहिले
S&P 500 Sinks 3.7% and Nasdaq Composite Goes Negative for the Year as Tech Sell-off Worsens
TradingView
·
१ घण्टा पहिले
Wall Street ends sharply lower on AI selloff, S&P 500, Dow in correction
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd